MetaADEDB 2.0 @ LMMD
Telbivudine
(IQFYYKKMVGJFEH-CSMHCCOUSA-N)
Structure
SMILES
OC[C@@H]1O[C@@H](C[C@H]1O)n1cc(C)c(=O)[nH]c1=O
Type(s)
Approved; Investigational
ATC code(s)
J05AF11
Molecular Formula:
C10H14N2O5
Molecular Weight:
242.229
Log P:
-1.5143
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
3
TPSA:
104.55
CAS Number(s):
3424-98-4; 26879-47-0
Synonym(s)
1.
Telbivudine
2.
1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione
3.
Telbivudin
4.
Tyzeka
5.
beta-L-2'-Deoxythymidine
6.
beta L 2' Deoxythymidine
External Link(s)
MeSHD000077712
PubChem Compound159269
BindingDB50088372
ChEBI63624
CHEMBLCHEMBL374731
DrugBankDB01265
DrugCentral4220
KEGGdr:D06675
Therapeutic Target DatabaseD0CL9S
ZINC2159
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Blood creatine phosphokinase increasedFAERS: 151
Canada Vigilance: 1
Canada Vigilance
US FAERS
2MyalgiaFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
3Drug exposure during pregnancyFAERS: 59US FAERS
4FatigueFAERS: 58
Canada Vigilance: 1
18201580CTD
Canada Vigilance
US FAERS
5RhabdomyolysisFAERS: 55US FAERS
6NauseaFAERS: 54US FAERS
7VomitingFAERS: 53US FAERS
8AstheniaFAERS: 52US FAERS
9Myoglobin blood increasedFAERS: 52US FAERS
10Maternal exposure during pregnancyFAERS: 37US FAERS
11MyopathyFAERS: 32US FAERS
12Blood lactate dehydrogenase increasedFAERS: 30US FAERS
13Blood creatine phosphokinase MB increasedFAERS: 28US FAERS
14Aspartate Aminotransferase IncreasedFAERS: 26US FAERS
15Hepatitis BFAERS: 2215388423
16152756
18816503
CTD
US FAERS
16Alanine Aminotransferase IncreasedFAERS: 20US FAERS
17Abdominal PainFAERS: 1918201580CTD
US FAERS
18Abdominal discomfortFAERS: 19US FAERS
19Hepatitis B DNA increasedFAERS: 19US FAERS
20Metabolic acidosisFAERS: 19US FAERS
21PainFAERS: 19US FAERS
22PalpitationsFAERS: 19US FAERS
23Chest discomfortFAERS: 18US FAERS
24GastritisFAERS: 17US FAERS
25AscitesFAERS: 13US FAERS
26ShockFAERS: 13US FAERS
27Drug resistanceFAERS: 12US FAERS
28jaundiceFAERS: 1220610938CTD
US FAERS
29ArthralgiaFAERS: 11US FAERS
30DizzinessFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
31HepatitisFAERS: 1120610938CTD
US FAERS
32Weight decreasedFAERS: 11US FAERS
33Blood pH decreasedFAERS: 10US FAERS
34MalaiseFAERS: 10US FAERS
35Electrolyte imbalanceFAERS: 9US FAERS
36Musculoskeletal stiffnessFAERS: 9US FAERS
37OliguriaFAERS: 9US FAERS
38PolymyositisFAERS: 9US FAERS
39PolyneuropathyFAERS: 9US FAERS
40AcidosisFAERS: 8US FAERS
41AnuriaFAERS: 8US FAERS
42Blood urea increasedFAERS: 8US FAERS
43DeafnessFAERS: 8US FAERS
44Musculoskeletal PainFAERS: 8US FAERS
45TinnitusFAERS: 8US FAERS
46Troponin increasedFAERS: 8US FAERS
47Blood creatinine increasedFAERS: 7US FAERS
48General physical health deteriorationFAERS: 7US FAERS
49HeadacheFAERS: 718201580CTD
US FAERS
50Hepatic EncephalopathyFAERS: 7US FAERS
51Infantile apnoeic attackFAERS: 7US FAERS
52MyositisFAERS: 7US FAERS
53Nerve injuryFAERS: 7US FAERS
54RalesFAERS: 7US FAERS
55Sinus TachycardiaFAERS: 7US FAERS
56SomnolenceFAERS: 7US FAERS
57Viral load increasedFAERS: 7US FAERS
58Abdominal rebound tendernessFAERS: 6US FAERS
59Abdominal tendernessFAERS: 6US FAERS
60Drug exposure via breast milkFAERS: 6US FAERS
61Drug ineffectiveFAERS: 6US FAERS
62Hepatitis B surface antigen positiveFAERS: 6US FAERS
63HyporeflexiaFAERS: 6US FAERS
64PCO2 decreasedFAERS: 6US FAERS
65PancreatitisFAERS: 6US FAERS
66Aldolase abnormalFAERS: 5US FAERS
67Alpha hydroxybutyrate dehydrogenase increasedFAERS: 5US FAERS
68AnxietyFAERS: 5US FAERS
69Base excess increasedFAERS: 5US FAERS
70Blood urine presentFAERS: 5US FAERS
71Chest PainFAERS: 5US FAERS
72Distributive shockFAERS: 5US FAERS
73DysgeusiaFAERS: 5US FAERS
74HypophagiaFAERS: 5US FAERS
75Limb discomfortFAERS: 5US FAERS
76Muscular DystrophyFAERS: 5US FAERS
77Amniotic fluid volume decreasedFAERS: 4US FAERS
78AsterixisFAERS: 4US FAERS
79Blood glucose increasedFAERS: 4US FAERS
80CyanosisFAERS: 4US FAERS
81Escherichia sepsisFAERS: 4US FAERS
82HypotensionFAERS: 4US FAERS
83Mechanical ventilationFAERS: 4US FAERS
84NasopharyngitisFAERS: 418201580CTD
US FAERS
85NephritisFAERS: 4US FAERS
86NeuralgiaFAERS: 4US FAERS
87Ocular icterusFAERS: 4US FAERS
88Respiratory FailureFAERS: 4US FAERS
89Respiratory distressFAERS: 4US FAERS
90RestlessnessFAERS: 4US FAERS
91Rheumatoid factor increasedFAERS: 4US FAERS
92TachycardiaFAERS: 4US FAERS
93muscle injuryFAERS: 4US FAERS
94Acute respiratory failureFAERS: 3US FAERS
95Allergic coughFAERS: 3US FAERS
96ArteriosclerosisFAERS: 3US FAERS
97AsthmaFAERS: 3US FAERS
98Axonal neuropathyFAERS: 3US FAERS
99Back PainFAERS: 3US FAERS
100Blood gases abnormalFAERS: 3US FAERS
101Cerebral cystFAERS: 3US FAERS
102Choking sensationFAERS: 3US FAERS
103ChokingFAERS: 3US FAERS
104CholestasisFAERS: 3US FAERS
105ChromaturiaFAERS: 3US FAERS
106ClaustrophobiaFAERS: 3US FAERS
107Completed SuicideFAERS: 3US FAERS
108DeliriumFAERS: 3US FAERS
109EcchymosisFAERS: 3US FAERS
110Ectopic PregnancyFAERS: 3US FAERS
111Electromyogram abnormalFAERS: 3US FAERS
112Erectile dysfunctionFAERS: 3US FAERS
113Exposure during breast feedingFAERS: 3US FAERS
114Feeling abnormalFAERS: 3US FAERS
115Feeling of body temperature changeFAERS: 3US FAERS
116Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
117HyperreflexiaFAERS: 3US FAERS
118InfectionFAERS: 3US FAERS
119Lumbar radiculopathyFAERS: 3US FAERS
120Muscle FatigueFAERS: 3US FAERS
121Myocardial necrosis marker increasedFAERS: 3US FAERS
122MyocarditisFAERS: 3US FAERS
123NephrolithiasisFAERS: 3US FAERS
124NeuritisFAERS: 3US FAERS
125Neurosensory hypoacusisFAERS: 3US FAERS
126Peripheral arterial occlusive diseaseFAERS: 3US FAERS
127PeritonitisFAERS: 3US FAERS
128PneumoniaFAERS: 3US FAERS
129PoikilocytosisFAERS: 3US FAERS
130Poor quality sleepFAERS: 3US FAERS
131ProteinuriaFAERS: 3US FAERS
132PruritusFAERS: 3US FAERS
133ToothacheFAERS: 3US FAERS
134Transaminases increasedFAERS: 3US FAERS
135Urine ketone body presentFAERS: 3US FAERS
136Ventricular internal diameter abnormalFAERS: 3US FAERS
137Vital functions abnormalFAERS: 3US FAERS
138effusionFAERS: 3US FAERS
139Acoustic stimulation tests abnormalFAERS: 2US FAERS
140AgeusiaFAERS: 2US FAERS
141AlopeciaFAERS: 2US FAERS
142AppendicitisFAERS: 2US FAERS
143ArthritisFAERS: 2US FAERS
144Blood creatine phosphokinaseFAERS: 2US FAERS
145Blood creatinine abnormalFAERS: 2US FAERS
146Blood potassium increasedFAERS: 2US FAERS
147Blood triglycerides increasedFAERS: 2US FAERS
148Blood urea abnormalFAERS: 2US FAERS
149Bullous lung diseaseFAERS: 2US FAERS
150Cardiac discomfortFAERS: 2US FAERS
151Cardiac enzymes increasedFAERS: 2US FAERS
152CardiomegalyFAERS: 2US FAERS
153CholecystitisFAERS: 2US FAERS
154CholelithiasisFAERS: 2US FAERS
155Cold sweatFAERS: 2US FAERS
156Decreased immune responsivenessFAERS: 2US FAERS
157DehydrationFAERS: 2US FAERS
158Diabetes MellitusFAERS: 2US FAERS
159Diastolic dysfunctionFAERS: 2US FAERS
160DysphoniaFAERS: 2US FAERS
161EosinophiliaFAERS: 2US FAERS
162Exposure via fatherFAERS: 2US FAERS
163Gastrointestinal sounds abnormalFAERS: 2US FAERS
164Gene MutationFAERS: 2US FAERS
165Head circumference abnormalFAERS: 2US FAERS
166Hepatitis B DNA assay positiveFAERS: 2US FAERS
167Hepatorenal SyndromeFAERS: 2US FAERS
168HypogeusiaFAERS: 2US FAERS
169Intentional drug misuseFAERS: 2US FAERS
170Irregular breathingFAERS: 2US FAERS
171Left atrial dilatationFAERS: 2US FAERS
172Lipase increasedFAERS: 2US FAERS
173LipomaFAERS: 2US FAERS
174Low birth weight babyFAERS: 2US FAERS
175Malignant neoplasm progressionFAERS: 2US FAERS
176Mitochondrial toxicityFAERS: 2US FAERS
177Musculoskeletal discomfortFAERS: 2US FAERS
178PallorFAERS: 2US FAERS
179Perinatal HBV infectionFAERS: 2US FAERS
180Portal HypertensionFAERS: 2US FAERS
181Pre-EclampsiaFAERS: 2US FAERS
182Protein urine presentFAERS: 2US FAERS
183RadiculitisFAERS: 2US FAERS
184SepsisFAERS: 2US FAERS
185SplenectomyFAERS: 2US FAERS
186SplenomegalyFAERS: 2US FAERS
187StillbirthFAERS: 2US FAERS
188Suicide attemptFAERS: 2US FAERS
189SyphilisFAERS: 2US FAERS
190Thyroid NeoplasmFAERS: 2US FAERS
191Toxicity to various agentsFAERS: 2US FAERS
192TuberculosisFAERS: 2US FAERS
193Ultrasound liver abnormalFAERS: 2US FAERS
194Victim of homicideFAERS: 2US FAERS
195White blood cell count decreasedFAERS: 2US FAERS
196Wound ComplicationFAERS: 2US FAERS
197treatment failureFAERS: 2US FAERS
198AbasiaFAERS: 1US FAERS
199Acute kidney injuryFAERS: 1US FAERS
200Anal sphincter atonyFAERS: 1US FAERS
201Anaphylactoid ReactionFAERS: 1US FAERS
202Angina PectorisFAERS: 1US FAERS
203AnorexiaFAERS: 1US FAERS
204Anti-HBe antibody positiveFAERS: 1US FAERS
205AphagiaFAERS: 1US FAERS
206AphasiaFAERS: 1US FAERS
207Apolipoprotein B increasedFAERS: 1US FAERS
208ArthropathyFAERS: 1US FAERS
209Bilirubin conjugated increasedFAERS: 1US FAERS
210Biopsy muscle abnormalFAERS: 1US FAERS
211BlindnessFAERS: 1US FAERS
212Blood albumin decreasedFAERS: 1US FAERS
213Blood bilirubin unconjugated increasedFAERS: 1US FAERS
214Blood cholesterol increasedFAERS: 1US FAERS
215Blood creatine increasedFAERS: 1US FAERS
216Blood creatine phosphokinase MBFAERS: 1US FAERS
217Blood creatine phosphokinase decreasedFAERS: 1US FAERS
218Blood creatinine decreasedFAERS: 1US FAERS
219Blood immunoglobulin G abnormalFAERS: 1US FAERS
220Blood potassium decreasedFAERS: 1US FAERS
221Blood urea nitrogen/creatinine ratio increasedFAERS: 1US FAERS
222BradycardiaFAERS: 1US FAERS
223Brain scan abnormalFAERS: 1US FAERS
224Cardiac ArrestFAERS: 1US FAERS
225Central nervous system lesionFAERS: 1US FAERS
226Cerebellar infarctionFAERS: 1US FAERS
227Cerebral PalsyFAERS: 1US FAERS
228Cerebral disorderFAERS: 1US FAERS
229Cerebrovascular accidentFAERS: 1US FAERS
230Chronic gastritisFAERS: 1US FAERS
231Cleft PalateFAERS: 1US FAERS
232Concomitant disease aggravatedFAERS: 1US FAERS
233Coronary Artery DiseaseFAERS: 1US FAERS
234CryingFAERS: 1US FAERS
235DiscomfortFAERS: 1US FAERS
236Disease ProgressionFAERS: 1US FAERS
237Duodenal UlcerFAERS: 1US FAERS
238DyspepsiaFAERS: 1US FAERS
239Echocardiogram abnormalFAERS: 1US FAERS
240EczemaFAERS: 1US FAERS
241Electrocardiogram abnormalFAERS: 1US FAERS
242Enzyme abnormalityFAERS: 1US FAERS
243EructationFAERS: 1US FAERS
244ErythemaFAERS: 1US FAERS
245Eye painFAERS: 1US FAERS
246FibrinolysisFAERS: 1US FAERS
247FlatulenceFAERS: 1US FAERS
248FrustrationFAERS: 1US FAERS
249Gastrointestinal carcinomaFAERS: 1US FAERS
250Gingival erythemaFAERS: 1US FAERS
251GlomerulonephritisFAERS: 1US FAERS
252GlossitisFAERS: 1US FAERS
253HemiparesisFAERS: 1US FAERS
254Hepatic InfectionFAERS: 1US FAERS
255Hepatitis B e antigen positiveFAERS: 1US FAERS
256Hepatitis CFAERS: 1US FAERS
257HydronephrosisFAERS: 1US FAERS
258Hyperemesis GravidarumFAERS: 1US FAERS
259HyperkeratosisFAERS: 1US FAERS
260HypersplenismFAERS: 1US FAERS
261Hyporesponsive to stimuliFAERS: 1US FAERS
262HypoxiaFAERS: 1US FAERS
263InflammationFAERS: 1US FAERS
264Influenza A virus test positiveFAERS: 1US FAERS
265InfluenzaFAERS: 1US FAERS
266LethargyFAERS: 1US FAERS
267LeukopeniaFAERS: 1US FAERS
268Liver carcinoma rupturedFAERS: 1US FAERS
269Liver transplant rejectionFAERS: 1US FAERS
270Low set earsFAERS: 1US FAERS
271LymphadenopathyFAERS: 1US FAERS
272MarasmusFAERS: 1US FAERS
273Maternal death during childbirthFAERS: 1US FAERS
274MeaslesFAERS: 1US FAERS
275Mental impairmentFAERS: 1US FAERS
276Mental status changesFAERS: 1US FAERS
277Mitochondrial enzyme deficiencyFAERS: 1US FAERS
278Multi-organ disorderFAERS: 1US FAERS
279Muscle necrosisFAERS: 1US FAERS
280Musculoskeletal chest painFAERS: 1US FAERS
281Myasthenia GravisFAERS: 1US FAERS
282Myocardial InfarctionFAERS: 1US FAERS
283MyoglobinuriaFAERS: 1US FAERS
284Nerve root injuryFAERS: 1US FAERS
285ObesityFAERS: 1US FAERS
286PO2 increasedFAERS: 1US FAERS
287Pain of skinFAERS: 1US FAERS
288PancytopeniaFAERS: 1US FAERS
289PetechiaeFAERS: 1US FAERS
290Pharyngolaryngeal PainFAERS: 1US FAERS
291PoisoningFAERS: 1US FAERS
292Post procedural complicationFAERS: 1US FAERS
293Pregnancy of partnerFAERS: 1US FAERS
294Pregnancy test negativeFAERS: 1US FAERS
295PregnancyFAERS: 1US FAERS
296Productive CoughFAERS: 1US FAERS
297Protein total increasedFAERS: 1US FAERS
298Pulmonary Valve StenosisFAERS: 1US FAERS
299Quality of life decreasedFAERS: 1US FAERS
300RadiculopathyFAERS: 1US FAERS
301Rebound effectFAERS: 1US FAERS
302RegurgitationFAERS: 1US FAERS
303Renal tubular disorderFAERS: 1US FAERS
304Retroperitoneal lymphadenopathyFAERS: 1US FAERS
305Septic ShockFAERS: 1US FAERS
306Sperm count abnormalFAERS: 1US FAERS
307Spermatozoa abnormalFAERS: 1US FAERS
308Spermatozoa morphology abnormalFAERS: 1US FAERS
309Spermatozoa progressive motility abnormalFAERS: 1US FAERS
310SpondylitisFAERS: 1US FAERS
311Sputum retentionFAERS: 1US FAERS
312Stem cell transplantFAERS: 1US FAERS
313Stevens-Johnson SyndromeFAERS: 1US FAERS
314Supportive careFAERS: 1US FAERS
315Suspected counterfeit productFAERS: 1US FAERS
316SyncopeFAERS: 1US FAERS
317Therapeutic response unexpectedFAERS: 1US FAERS
318Throat irritationFAERS: 1US FAERS
319ThyroidectomyFAERS: 1US FAERS
320Transaminases abnormalFAERS: 1US FAERS
321Trendelenburg's symptomFAERS: 1US FAERS
322Troponin I increasedFAERS: 1US FAERS
323Troponin T increasedFAERS: 1US FAERS
324Unresponsive to stimuliFAERS: 1US FAERS
325Urine bilirubin increasedFAERS: 1US FAERS
326VIIth nerve paralysisFAERS: 1US FAERS
327VasculitisFAERS: 1US FAERS
328Ventricular arrhythmiaFAERS: 1US FAERS
329VertigoFAERS: 1US FAERS
330Viral mutation identifiedFAERS: 1US FAERS
331Wrong drug administeredFAERS: 1US FAERS
332Wrong technique in product usage processFAERS: 1US FAERS
333XerodermaFAERS: 1US FAERS
334nervous system disorderFAERS: 1US FAERS
335Hepatitis B, Chronic

View details

CTD
336Respiratory Tract Infections18201580CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.